Compositionand Description
OLVAXTAR-A®, inactivated hepatitis Avaccine is derived from hepatitis A virus cultured in human diploid cell,followed by harvest, purification, inactivation by formaldehyde and aluminiumadsorption. OLVAXTAR-A® is a purified sterile suspension.
Active Ingredient: Inactivated hepatitis Avirus antigen
Excipients: Aluminium hydroxide, sodiumdihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, and waterfor injection.
No preservative in Healive®.
TargetGroups For Vaccination
Susceptible people aged over 12 months.
TherapeuticIndication
Healive® can induce body to generateimmunoreaction against hepatitis A virus, and can be used for prevention ofinfection caused by hepatitis A virus.
Strength
Each package contains 0.5ml or 1.0ml.Single dose of 1.0ml containing 500u is for adult use. Single dose of 0.5mlcontaining 250u is for junior use.
Back
